Soleno Therapeutics (SLNO)

• Market cap: $2.1B
• 1 day: 4.72%
• 5 days: 7.05%
• 1 month: -4.2%
• 3 months: -17.6%
• 6 months: -38.34%
• Year to date: -13.06%
• 1 year: -8.58%
• 5 years: 8.06%
• 10 years: -54.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152